DSIPExplore study findings
What a Controlled DSIP Insomnia Study Found
2 numbered sourcesSource years 1992, 2026
Peptides are short amino-acid chains held together by peptide bonds. Some are investigated because they may change signaling, but a clinical study has to show whether people feel or function better. DSIP, or emideltide, is a nine-amino-acid peptide studied in sleep research. The question here is whether it improved chronic insomnia, a condition involving trouble sleeping together with consequences during the day. The 2026 FDA appraisal found that the human evidence remains inconclusive. The original trials available for this question are older. [1, 2]
In a 1992 study, Frédéric Bes and colleagues compared DSIP with a placebo in 16 people with chronic insomnia. Participants spent five nights in a sleep laboratory, including an adaptation night and a baseline night. The double-blind design reduced the chance that knowing who received the peptide would influence the measurements. The team recorded sleep with polysomnography and also asked participants about sleep quality and tiredness. Both types of measurement mattered because a person can spend more of the night asleep without necessarily feeling more rested. [2]
Compared with placebo, the peptide group showed shorter time to fall asleep and higher sleep efficiency on some recorded measures. The investigators judged the differences weak and noted that a change in the placebo group may have contributed. There was no change in subjective sleep quality. The study was small, short and measured several outcomes. Those features limit how much weight a reader should give the isolated differences. The researchers did not interpret the results as a major therapeutic benefit. [2]
FDA reviewers in 2026 found that early results across studies did not line up consistently, and they did not find an effectiveness study for the nominated route under review. The better question for new trials would be whether improvements persist and matter to people during the day, with a sufficiently large comparison group and prespecified measures. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
